Paper856437
High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis.
Hayes DM and 5 others. Cancer, 1977. Cited by 636 papers, by iCite.
Cite this record
ConductScience Library. High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis. Papers, record 856437. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/856437
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- High dose cis-platinum diammine dichloride: amelioration of renal toxicity by mannitol diuresis.
- PubMed
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cisplatin | Major topic |
| Diuresis | Major topic |
| Kidney | Major topic |
| Mannitol | Major topic |
| Neoplasms | Major topic |
| Adenocarcinoma | |
| Adult | |
| Aged | |
| Creatinine | |
| Dysgerminoma | |
| Female | |
| Gastrointestinal Neoplasms | |
| Head and Neck Neoplasms | |
| Hearing | |
| Humans | |
| Infusions, Parenteral | |
| Injections, Intravenous | |
| Lung Neoplasms | |
| Male | |
| Middle Aged | |
| Ovarian Neoplasms | |
| Testicular Neoplasms |
Source PubMed
Cited by117
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 636 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40465128 | Guidance on the short hydration method for cisplatin administration. | Int J Clin Oncol | 2025 | https://conductscience.org/library/papers/40465128 | PubMed |
| 39989079 | Effect of hydration schedules on dose-limiting toxicity in patients with head and neck squamous cell carcinoma treated with cisplatin. | Br J Clin Pharmacol | 2025 | https://conductscience.org/library/papers/39989079 | PubMed |
| 39415423 | Effect of mannitol on cisplatin-associated acute kidney injury: a target trial emulation. | Nephrol Dial Transplant | 2025 | https://conductscience.org/library/papers/39415423 | PubMed |
| 38564107 | Magnesium supplementation therapy to prevent cisplatin-induced acute nephrotoxicity in pediatric cancer: a randomized phase-2 trial. | Int J Clin Oncol | 2024 | https://conductscience.org/library/papers/38564107 | PubMed |
| 37242892 | Hyaluronic Acid-Based Nanocarriers for Anticancer Drug Delivery. | Polymers (Basel) | 2023 | https://conductscience.org/library/papers/37242892 | PubMed |
| 35806229 | Pro-Inflammatory Signalling PRRopels Cisplatin-Induced Toxicity. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35806229 | PubMed |
| 35413808 | The effect of mannitol addition to hydration on acute kidney injury event after high dose cisplatin chemotherapy: an ambispective cohort study. | BMC Cancer | 2022 | https://conductscience.org/library/papers/35413808 | PubMed |
| 35002308 | Correlation Between Higher Cumulative Dose of Cisplatin for Concurrent Chemoradiation and Acute Kidney Disease Incidence Among Nasopharyngeal Carcinoma Patients: A Comparative Study. | Int J Gen Med | 2021 | https://conductscience.org/library/papers/35002308 | PubMed |
| 33415542 | Early Physiological and Cellular Indicators of Cisplatin-Induced Ototoxicity. | J Assoc Res Otolaryngol | 2021 | https://conductscience.org/library/papers/33415542 | PubMed |
| 32862356 | Effect of mannitol on acute kidney injury induced by cisplatin. | Support Care Cancer | 2021 | https://conductscience.org/library/papers/32862356 | PubMed |
| 32740717 | Short hydration with 20 mEq of magnesium supplementation for lung cancer patients receiving cisplatin-based chemotherapy: a prospective study. | Int J Clin Oncol | 2020 | https://conductscience.org/library/papers/32740717 | PubMed |
| 32720645 | The identification of dual protective agents against cisplatin-induced oto- and nephrotoxicity using the zebrafish model. | Elife | 2020 | https://conductscience.org/library/papers/32720645 | PubMed |
| 32290299 | Molecular and Cellular Mechanisms of Cytotoxic Activity of Vanadium Compounds against Cancer Cells. | Molecules | 2020 | https://conductscience.org/library/papers/32290299 | PubMed |
| 31886208 | Citrus aurantium Ameliorates Cisplatin-Induced Nephrotoxicity. | Biomed Res Int | 2019 | https://conductscience.org/library/papers/31886208 | PubMed |
| 31811602 | Prognostic significance of hyponatremia induced by systemic chemotherapy in a hospital-based propensity score-matched analysis. | Int J Clin Oncol | 2020 | https://conductscience.org/library/papers/31811602 | PubMed |
| 31429065 | Prevention of Cisplatin-Induced Acute Kidney Injury: A Systematic Review and Meta-Analysis. | Drugs | 2019 | https://conductscience.org/library/papers/31429065 | PubMed |
| 31355359 | Intramuscular administration of hexachloroplatinate reverses cyanide-induced metabolic derangements and counteracts severe cyanide poisoning. | FASEB Bioadv | 2019 | https://conductscience.org/library/papers/31355359 | PubMed |
| 30167970 | Evaluation of the effect of acetazolamide versus mannitol on cisplatin-induced nephrotoxicity, a pilot study. | Int J Clin Pharm | 2018 | https://conductscience.org/library/papers/30167970 | PubMed |
| 30157247 | BAMLET kills chemotherapy-resistant mesothelioma cells, holding oleic acid in an activated cytotoxic state. | PLoS One | 2018 | https://conductscience.org/library/papers/30157247 | PubMed |
| 29765771 | Reduction in nephrotoxicities using short hydration for chemotherapy containing cisplatin: a consecutive analysis of 467 patients with thoracic malignancies. | ESMO Open | 2018 | https://conductscience.org/library/papers/29765771 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/856437
GET https://conductscience.org/api/papers/v1/856437/cited_by?page=2